Central serous chorioretinopathy: A review
Clinical & Experimental Ophthalmology · 2023-04 · 51 (3) · 243-270
DOI: 10.1111/ceo.14201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 30.01.2023. Verfasst von Adrian T Fung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Westmead Hospital, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Choroid Diseases, Photochemotherapy. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy associated with fluid leakage. The pathogenesis is not yet completely understood, but changes in the choroid, sclera and RPE have been described associated with venous congestion of choroidal outflow. CSC can be categorised into acute, chronic, and recurrent subtypes with recent classifications of simple and complex based on the area of RPE change seen on fundus autofluorescence. A multimodal imaging approach is helpful in the diagnosis and management of CSC and secondary complications such as type 1 neovascularisation. Although spontaneous resolution with relatively good visual outcomes is common, treatment should be considered in patients with persistent or recurrent SRF. Treatment options include laser, systemic medications, intravitreal therapy, and surgery. Of these, argon laser for focal extramacular fluid leaks and photodynamic therapy of leakage identified by indocyanine‐green angiography currently have the greatest supportive evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Westmead Hospital, Westmead, New South Wales, Australia.
- Westmead and Central Clinical Schools, Specialty of Clinical Ophthalmology and Eye Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Ophthalmology, Faculty of Medicine, Health and Human Sciences, Macquarie University, New South Wales, Australia.
- Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia.
- Sydney Eye Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Adrian T Fung, Yi Yang, Andrew W Kam
Zitieren
APA
Fung, A. T., Yang, Y., & Kam, A. W. (2023). Central serous chorioretinopathy: A review. Clinical & Experimental Ophthalmology, 51(3), 243-270. https://doi.org/10.1111/ceo.14201
Vancouver
Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: A review. Clinical & Experimental Ophthalmology. 2023;51(3):243-270. doi:10.1111/ceo.14201
BibTeX
@article{Fung2023,
author = {Fung, Adrian T and Yang, Yi and Kam, Andrew W},
title = {Central serous chorioretinopathy: A review},
journal = {Clinical & Experimental Ophthalmology},
year = {2023},
volume = {51},
number = {3},
pages = {243--270},
doi = {10.1111/ceo.14201}
}
EUVIMED